| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-124722 |
| M.Wt: | 494.63 |
| Formula: | C24H42N6O5 |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
OHM1 is an analog of HIF1α CTAD that inhibits its binding with p300/CBP. OHM1 targets CH1 domain with an affinity of 0.53 μM[1].
In Vitro:OHM1 (1-20 μM; 24 h) results in a dose-dependent reduction in the HIF promoter activity, and reduces the level of HIF1α transcriptional activity under hypoxia to that observed under normoxia at 20 μM in MDA-MB-231 cells[1].
OHM1 down-regulates hypoxia-inducible gene expression[1].
OHM1 (10 μM) down-regulates multiple genes implicated in angiogenesis, apoptosis, cell proliferation, and invasion, along with several cancer-specific markers in the A549 non-small-cell lung cancer cell line[1].
In Vivo:OHM1 (15 mg/kg; i.p.; every other day for 15 injections) reduces MDA-MB-231 tumor volume in mice[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.